Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lophatananon

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Rheumatology (Oxford, England)|January 17, 2002
A nurse-delivered advice intervention can reduce chronic non-steroidal anti-inflammatory drug use in general practice: a randomized controlled trialA C Jones, L Coulson, K Muir, et al.
BMC Medicine|March 2, 2018
The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation studyV J Gnanapragasam, O Bratt, K Muir, et al.
British Journal of Cancer|May 29, 2008
Diagnostic radiation procedures and risk of prostate cancerP Myles, S Evans, A Lophatananon, et al.
British Journal of Cancer|December 2, 2010
Hand pattern indicates prostate cancer riskA A Rahman, A Lophatananon, S Stewart-Brown, et al.
British Journal of Cancer|June 1, 2013
A personalised approach to prostate cancer screening based on genotyping of risk founder allelesC Cybulski, D Wokołorczyk, W Kluźniak, et al.
British Journal of Cancer|February 20, 2014
FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association ConsortiumD Agarwal, S Pineda, K Michailidou, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Rheumatology (Oxford, England)|January 17, 2002
A nurse-delivered advice intervention can reduce chronic non-steroidal anti-inflammatory drug use in general practice: a randomized controlled trialA C Jones, L Coulson, K Muir, et al.
BMC Medicine|March 2, 2018
The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation studyV J Gnanapragasam, O Bratt, K Muir, et al.
British Journal of Cancer|May 29, 2008
Diagnostic radiation procedures and risk of prostate cancerP Myles, S Evans, A Lophatananon, et al.
British Journal of Cancer|December 2, 2010
Hand pattern indicates prostate cancer riskA A Rahman, A Lophatananon, S Stewart-Brown, et al.
British Journal of Cancer|June 1, 2013
A personalised approach to prostate cancer screening based on genotyping of risk founder allelesC Cybulski, D Wokołorczyk, W Kluźniak, et al.
British Journal of Cancer|February 20, 2014
FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association ConsortiumD Agarwal, S Pineda, K Michailidou, et al.
Pageof 1